Skip to content

The effect ambulation on nausea and pain in patients undergoing inguinal hernia surgery

The effect of evidence-based ambulation on nausea and pain in patients undergoing inguinal hernia surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016082729550N1
Enrollment
60
Registered
2017-01-22
Start date
2016-11-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Unilateral or unspecified inguinal hernia, without obstruction or gangrene

Interventions

Intervention 1: In the control group, the researchers don’t any intervention and the ambulate patient usually done by physician's written order vital signs, severity and frequency of nausea and pain
Early detection
In the control group, the researchers don’t any intervention and the ambulate patient usually done by physician's written order vital signs, severity and frequency of nausea and pain Checked each hou
Researcher checked vital signs the frequency and severity of nausea and pain, after Consciousness and log in patient the section, and recorded in form. Regular monitoring patient continues every 1

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age group 15-50 years with uncomplicated unilateral inguinal hernia; patients agreed to participate in the scheme; have stable vital signs; don’t have electrolyte imbalance; don’t have malnutrition; don’t have /has chronic diseases like liver problems, cancer and immune system defects have decreased; consciousness enough to determine the severity of nausea and pain. Exclusion criteria: use of drugs that reduce nausea and vomiting; re-operation same area (hernia or varicocele); complicated hernia(incarcerate—strangulate); smoking; movement disorder or have lower limbs problems; drug addiction; nausea and vomiting Pre-operative; don’t satisfactory to continue research; patient died.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before and after intervention. Method of measurement: VAS assessment.;Nausea. Timepoint: Before and after intervention. Method of measurement: VAS assessment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ghazi

Sabzevar University of Medical Sciences

zahra.nurse@gmail.com; ali.daneshvari@gmail.com+98 51 4444 6070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026